摘要
目的探讨认知障碍简明评价表(Cog-12量表)对帕金森病(PD)患者轻度认知功能障碍的诊断价值。方法将85例PD患者按认知障碍诊断标准分为认知功能正常组(45例)、轻度认知功能障碍组(PD-MCI)组(40例)。采用Cog-12量表、蒙特利尔认知评估量表(MoCA)及MMSE量表对患者进行测评,分析3个量表对PD患者轻度认知障碍的筛查能力。结果与认知功能正常组比较,PD-MCI组Cog-12量表评分显著升高,MoCA、MMSE量表评分显著降低(均P<0.001)。Cog-12对PD患者MCI的鉴别能力明显优于MoCA、MMSE(AUC_(Cog-12)=0.958,敏感度为85.7%,特异度为75%;AUC_(MMSE)=0.798,敏感度为52.4%,特异度为26.5%;AUC_(MoCA)=0.907,敏感度为71.4%,特异度为21.5%)。当Cog-12界值为7.5分时,其敏感性为85.7%。结论 Cog-12量表可有效检测PD患者的认知功能损伤,可应用于临床PD患者认知功能的筛查。
Objective To explore the diagnostic value of cognitive-12 scale( Cog-12 scale) on mild cognitive impairment( MCI) in Parkinson's disease( PD). Methods Eighty-five PD patients were divided into normal cognitive function group( 45 cases) and mild cognitive impairment( PD-MCI) group( 40 cases) by cognitive disorder diagnostic criteria. Cog-12 scale,Montreal cognitive assessment scale( MoCA),MMSE weight tables for patient evaluation,analysis of them on PD patients with mild cognitive impairment screen. Results Compared with normal cognitive function group,the score of Cog-12 scale was significantly increased,scores of MoCA and MMSE were significantly decreased( all P〈0. 001). The discriminating ability of Cog-12 diagnosed MCI in PD patients was better than MoCA and MMSE( AUCCog-12= 0. 958,sensitivity was 85. 7%,specificity was 75%; AUCMMSE= 0. 798,sensitivity was 52. 4%,specificity was 26. 5%; AUCMoCA= 0. 907,sensitivity was 71. 4%, specificity was21. 5%). The area under ROC curve showed that the sensitivity of Cog-12 score in predicting MCI was 85. 7% when its cutoff value was 7. 5. Conclusions Cog-12 scale can be effective in detecting cognitive impairment in patients with PD. It can be applied to clinical screening for cognitive dysfunction in PD patients.
作者
王谟兰
徐俊
朱晓峰
徐耀
张桁忠
WANG Mo-lan XU Jun ZHU Xiao-feng et al(Jiangsu Provincial Yangzhou Wutaishan Hospital, Yangzhou 225001, China)
出处
《临床神经病学杂志》
北大核心
2017年第5期333-336,共4页
Journal of Clinical Neurology